A substantial increase in the incidence of osteoarthritis further propels the Global Viscosupplementation Market Growth

Published: May 2021

The global viscosupplementation market is anticipated to grow at a CAGR of around 8.6% during the forecast period (2021-2027). The key factors that driving market growth include the increasing prevalence of osteoarthritis across the globe coupled with the rising demand for viscosupplementation. For instance, according to Centre for Disease Control and Prevention estimation of 1 in 4 (or 54.4 million), Although there are more than 100 types of arthritis, osteoarthritis (OA) is the most common, affecting 32.5 million adults in the US. Adults in the US suffer from arthritis, with the number expected to rise to 78 million by 2040. Further, improvement in healthcare infrastructure and providence of medical assistance also drive the market. For instance, according to Commonwealth Fund, in 2018, almost 92% of the population got medical insurance coverage in the US and almost 55% population was covered under Employer-sponsored health insurance.

Browse the full report description of "Global Viscosupplementation System Market Size, Share & Trends Analysis Report by Product (Single-Injection, Three-Injection, and Five-Injection) By Application (Knee, Hip, Ankle, and Others) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/viscosupplementation-market

Moreover, significant advancement in the viscosupplementation by the major players in the market also propel the growth of the market. For instance, in January 2019, OrthogenRx introduced TriVisc, a sodium hyaluronate for the treatment of knee osteoarthritis in a three-injection regimen in the US. TriVisc is the least expensive in terms of price and this launch will be allowing OrthogenRx to stay the course in providing healthcare practitioners and patients with reasonable and reliable pricing for all goods.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Product

o By Application

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc, Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., Zimmer Biomet Holdings, Inc., and others 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Viscosupplementation Market Report Segment

By Product

  • Single-Injection
  • Three-Injection
  • Five-Injection

By Application

  • Knee
  • Hip
  • Ankle
  • Others

Global Viscosupplementation Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/viscosupplementation-market